Floatz logo

Naltrexone

Alcohol Use Disorder

VA Connecticut Healthcare SystemSmall moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Alcohol Use Disorder cohort.

Asset / SponsorPhaseRating
Cipralex
University of Texas Southwestern Medical Center
Phase 4BBB
Seroquel®
University of Cincinnati
Phase 4BBB
Topamax
University of California, San Francisco
Phase 4BB
Risperdal
Dartmouth-Hitchcock Medical Center
Phase 4BB
17.BETA.-(1-KETOETHYL)-.DELTA. SUP(5)-ANDROSTEN-3.BETA.-OL
Sherwood Brown, MD, PhD
Phase 4BB

View all 28 →

Same molecule, other indications

Naltrexone is also rated in:

alcohol dependenceDormant
BBB
Indicative ·
79 / 100
View asset →
nicotine dependenceDormant
BBB
Indicative ·
76 / 100
View asset →
osteoarthritisDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →